Filter
300
Filtered Results: 300
Text search:
chemoprophylaxis
Featured
Recommendations
36
New Publications
84
Language
Document type
No document type
204
Guidelines
52
Studies & Reports
21
Manuals
9
Strategic & Response Plan
6
Training Material
3
Infographics
2
Fact sheets
2
Brochures
1
Countries / Regions
India
33
Western and Central Europe
15
Germany
13
South Africa
13
Global
10
Kenya
8
Ethiopia
8
Eastern Europe
6
Zambia
6
Nepal
5
Tanzania
5
Botswana
5
Ghana
4
Sierra Leone
4
Philippines
4
Africa
4
Russia
4
Ukraine
3
Rwanda
3
Nigeria
3
Uganda
3
Brazil
3
Madagascar
3
Lesotho
2
Cameroon
2
Senegal
2
Zimbabwe
2
Asia
2
Congo, Democratic Republic of
2
Eswatini/ Swaziland
2
North Macedonia
1
Gambia
1
Albania
1
Burkina Faso
1
Malawi
1
USA
1
Cambodia
1
Argentina
1
Namibia
1
Angola
1
Liberia
1
Authors & Publishers
Publication Years
Category
Countries
113
Clinical Guidelines
52
Public Health
22
Key Resources
9
Women & Child Health
8
Capacity Building
5
Pharmacy & Technologies
2
Toolboxes
TB
49
HIV
41
Rapid Response
31
NTDs
14
Refugee
8
Cholera
8
Ebola & Marburg
6
COVID-19
6
Mental Health
5
Polio
4
Pharmacy
3
Conflict
3
NCDs
2
Zika
2
AMR
2
Specific Hazards
1
Planetary Health
1
Health Financing Toolbox
1
PLOS ONE | www.plosone.org
May 2013 | Volume 8 | Issue 5 | e63476
Reach the Unreached - FIND, TREAT, CURE TB, SAVE LIVES
The World Health Organization organized a Consultation of National Leprosy Programme managers, partners and affected persons to discuss the draft Global Leprosy Strategy, 2021--2030. This virtual event took place from 26 to 30 October 2020. It was attended by more than 450 stakeholders. Contribution...
Arsenical monotherapies were previously very successful for treating human African trypanosomiasis (HAT).
Melarsoprol resistance emerged as early as the 1970s and was widespread by the late 1990s.
Melarsoprol resistance represents the only example of widespread drug resistance in HAT patients wher...
Research
Emerging Infectious Diseases Vol. 12, No. 5, May 2006
PLOS ONE | DOI:10.1371/journal.pone.0142290 November 9, 2015; 1 / 16
Module 4
Leaders
July 2017
Module 4: Leaders. This module aims to inform and update leaders and decision-makers about PrEP. It provides information on the benefits and limitations of PrEP so that they can consider how PrEP could be effectively implemented in their own settings. It also contai...
Revised National Tuberculosis Control Programme
Asthma prevalence is increasing worldwide and surveys indicate that the majority of patients in developed and developing countries do not receive optimal care and are therefore not well controlled. The aim of these guidelines is to promote a better standard of treatment based on advances in the unde...
There is a broad consensus nowadays that the Earth is warming up as a result of greenhouse gas emissions caused by anthropogenic activities. It is also clear that current trends in the fields of energy, development and population growth will lead to continuous and ever more dramatic climate change. ...
The Pharmaceutical Forum of the Americas (PFA) has previously published guidelines and organised campaigns for community pharmacists on the prevention, detection and control of arbovirus infections in 2018 with a grant from the FIP Foundation for Pharmacy Education and Research. Building on that exp...
Joining efforts to control two trelated global epidemics.
National Center for HIV/AIDS, Viral Hepatitis, STD, and TB Prevention.
Division of Tuberculosis Elimination.
Módulo 1
Clínico
Julho de 2017
Módulo 1: Clínico. Este módulo é destinado a profissionais de saúde como médicos, enfermeiros e auxiliares e traz um resumo sobre como prover a PrEP de forma segura e efetiva, abordando vários aspectos: triagem de pessoas com risco substancial de contr...
Documentation of Best Practices and Bottlenecks to Program Implementation in Senegal
SUMMARY REPORT
Accessed at March 2014
